货币 / KROS
KROS: Keros Therapeutics Inc
14.41
USD
0.25
(1.71%)
今日KROS汇率已更改-1.71%。当日,交易品种以低点14.35和高点14.80进行交易。
关注Keros Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KROS新闻
- Zacks KROS vs. EXAS: Which Stock Should Value Investors Buy Now?
- Zacks Will Reblozyl Enable BMY to Offset the Impact of Generic Competition?
- Seeking Alpha ClearBridge Small Cap Strategy Q2 2025 Commentary
- Zacks RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
- Zacks FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
- Investing Keros Therapeutics doses first patient in Phase 3 MDS trial
- Reuters Fat, not muscle: drugmakers in race for next weight-loss breakthrough
- Benzinga Keros Therapeutics' Quiet Near-Term Outlook Overshadows Pipeline Potential: Analyst - Keros Therapeutics (NASDAQ:KROS)
- Investing BofA cuts Keros Therapeutics stock rating, price target to $18
- Investing Keros directors face significant shareholder dissent
- Investing Keros Therapeutics to return $375 million to shareholders
- Investing Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
- Benzinga Keros Therapeutics Stops PAH Drug Development, Shrinks Workforce By 45% - Keros Therapeutics (NASDAQ:KROS)
- Investing Keros Therapeutics halts PAH drug development, cuts workforce
- Investing Keros secures Glass Lewis support for director nominees
- Investing ADAR1 calls for Keros to release review results before vote
- Investing Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
- Seeking Alpha Keros Therapeutics (KROS): Strategic Alternatives Could Bring About Value Creation
- Benzinga Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Keros Therapeutics (NASDAQ:KROS)
- Benzinga Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - CarMax (NYSE:KMX), Keros Therapeutics (NASDAQ:KROS)
- Benzinga PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday - Enact Holdings (NASDAQ:ACT), DexCom (NASDAQ:DXCM)
- Seeking Alpha Keros Therapeutics: Losing Its Lead Drug Is Bad Medicine (NASDAQ:KROS)
- Seeking Alpha Fidelity Select Health Care Portfolio Q4 2024 Review (Mutual Fund:FSPHX)
日范围
14.35
14.80
年范围
9.12
72.37
- 前一天收盘价
- 14.48
- 开盘价
- 14.66
- 卖价
- 14.41
- 买价
- 14.71
- 最低价
- 14.35
- 最高价
- 14.80
- 交易量
- 812
- 日变化
- -1.71%
- 月变化
- 8.18%
- 6个月变化
- 29.59%
- 年变化
- -71.40%
30 七月, 星期三
12:15
USD
- 实际值
- 104 K
- 预测值
- 57 K
- 前值
- -33 K
12:30
USD
- 实际值
- 3.0%
- 预测值
- 0.4%
- 前值
- -0.5%
12:30
USD
- 实际值
- 2.0%
- 预测值
- 3.6%
- 前值
- 3.8%
12:30
USD
- 实际值
- 2.5%
- 预测值
- 3.3%
- 前值
- 3.5%
12:30
USD
- 实际值
- 2.1%
- 预测值
- 3.1%
- 前值
- 3.7%
12:30
USD
- 实际值
- 1.4%
- 预测值
- 0.8%
- 前值
- 0.5%
12:30
USD
- 实际值
- 6.3%
- 预测值
- -1.5%
- 前值
- -3.1%
14:00
USD
- 实际值
- -0.8%
- 预测值
- 1.6%
- 前值
- 1.8%
14:00
USD
- 实际值
- -2.8%
- 预测值
- 9.6%
- 前值
- 1.1%
14:00
USD
- 实际值
- 72.0
- 预测值
- 前值
- 72.6
14:30
USD
- 实际值
- 7.698 M
- 预测值
- 0.914 M
- 前值
- -3.169 M
14:30
USD
- 实际值
- 0.690 M
- 预测值
- 0.114 M
- 前值
- 0.455 M
14:30
USD
- 实际值
- 1.317 M
- 预测值
- 0.738 M
- 前值
- -0.740 M
14:30
USD
- 实际值
- 0.130 M
- 预测值
- -0.004 M
- 前值
- 0.095 M
14:30
USD
- 实际值
- 3.635 M
- 预测值
- -0.111 M
- 前值
- 2.931 M
14:30
USD
- 实际值
- 0.676 M
- 预测值
- 0.915 M
- 前值
- 0.282 M
14:30
USD
- 实际值
- 0.739 M
- 预测值
- 0.608 M
- 前值
- 0.003 M
14:30
USD
- 实际值
- -2.724 M
- 预测值
- 0.879 M
- 前值
- -1.738 M
14:30
USD
- 实际值
- -0.025 M
- 预测值
- 前值
- 0.087 M
14:30
USD
- 实际值
- -0.1%
- 预测值
- 前值
- 1.6%
18:00
USD
- 实际值
- 预测值
- 前值
18:00
USD
- 实际值
- 4.50%
- 预测值
- 前值
- 4.50%
18:30
USD
- 实际值
- 预测值
- 前值